HEADER HYDROLASE/HYDROLASE INHIBITOR 20-SEP-12 4H76 TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX TITLE 2 WITH A BROAD SPECTRUM HYDROXAMATE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE METALLOELASTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HUMAN MMP12 CATALYTIC DOMAIN: UNP RESIDUES 106-263; COMPND 5 SYNONYM: MME, MACROPHAGE ELASTASE, ME, HME, MATRIX METALLOPROTEINASE- COMPND 6 12, MMP-12; COMPND 7 EC: 3.4.24.65; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HME, MMP12; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS BROAD SPECTRUM MMP HYDROXAMATE INHIBITOR, METZINCIN, ZINC PROTEASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.A.STURA,L.VERA,E.CASSAR-LAJEUNESSE,E.NUTI,V.DIVE,A.ROSSELLO REVDAT 5 20-SEP-23 4H76 1 REMARK SEQADV LINK REVDAT 4 12-AUG-15 4H76 1 JRNL REVDAT 3 08-OCT-14 4H76 1 AUTHOR REVDAT 2 01-MAY-13 4H76 1 AUTHOR REVDAT 1 24-APR-13 4H76 0 JRNL AUTH C.ANTONI,L.VERA,L.DEVEL,M.P.CATALANI,B.CZARNY, JRNL AUTH 2 E.CASSAR-LAJEUNESSE,E.NUTI,A.ROSSELLO,V.DIVE,E.A.STURA JRNL TITL CRYSTALLIZATION OF BI-FUNCTIONAL LIGAND PROTEIN COMPLEXES. JRNL REF J.STRUCT.BIOL. V. 182 246 2013 JRNL REFN ISSN 1047-8477 JRNL PMID 23567804 JRNL DOI 10.1016/J.JSB.2013.03.015 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.ANTONI,L.VERA,L.DEVEL,M.P.CATALANI,B.CZARNY, REMARK 1 AUTH 2 E.CASSAR-LAJEUNESSE,E.NUTI,A.ROSSELLO,V.DIVE,E.A.STURA REMARK 1 TITL CRYSTALLIZATION OF BI-FUNCTIONAL LIGAND PROTEIN COMPLEXES. REMARK 1 REF J.STRUCT.BIOL. V. 12 2441 2013 REMARK 1 REFN ISSN 1047-8477 REMARK 1 PMID 23567804 REMARK 1 DOI 10.1016/J.JSB.2013.03.015 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.ROSSELLO,E.NUTI,E.ORLANDINI,P.CARELLI,S.RAPPOSELLI, REMARK 1 AUTH 2 M.MACCHIA,F.MINUTOLO,L.CARBONARO,A.ALBINI,R.BENELLI, REMARK 1 AUTH 3 G.CERCIGNANI,G.MURPHY,A.BALSAMO REMARK 1 TITL NEW N-ARYLSULFONYL-N-ALKOXYAMINOACETOHYDROXAMIC ACIDS AS REMARK 1 TITL 2 SELECTIVE INHIBITORS OF GELATINASE A (MMP-2). REMARK 1 REF BIOORG.MED.CHEM. V. 12 2441 2004 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 15080939 REMARK 1 DOI 10.1016/J.BMC.2004.01.047 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.76 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 27413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1371 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.7812 - 3.2246 1.00 2785 147 0.1542 0.1706 REMARK 3 2 3.2246 - 2.5595 1.00 2651 140 0.1612 0.1837 REMARK 3 3 2.5595 - 2.2360 1.00 2616 137 0.1669 0.2030 REMARK 3 4 2.2360 - 2.0316 1.00 2609 138 0.1564 0.1673 REMARK 3 5 2.0316 - 1.8859 1.00 2575 135 0.1515 0.1909 REMARK 3 6 1.8859 - 1.7747 1.00 2590 137 0.1651 0.1725 REMARK 3 7 1.7747 - 1.6859 1.00 2593 136 0.1708 0.2135 REMARK 3 8 1.6859 - 1.6125 1.00 2571 135 0.1866 0.2466 REMARK 3 9 1.6125 - 1.5504 1.00 2575 136 0.2040 0.2207 REMARK 3 10 1.5504 - 1.4969 0.97 2477 130 0.2284 0.2341 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.13 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1504 REMARK 3 ANGLE : 1.079 2041 REMARK 3 CHIRALITY : 0.076 205 REMARK 3 PLANARITY : 0.005 268 REMARK 3 DIHEDRAL : 16.441 553 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4H76 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000075104. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : HORIZONTALLY DIFFRACTING SI REMARK 200 (111) MONOCHROMATOR AND PT REMARK 200 COATED MIRRORS IN KIRKPATRICK- REMARK 200 BAEZ GEOMETRY FOR FOCUSING REMARK 200 OPTICS : BENT CYLINDRICAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27420 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.980 REMARK 200 R MERGE (I) : 0.11400 REMARK 200 R SYM (I) : 0.10700 REMARK 200 FOR THE DATA SET : 14.2100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 7.92 REMARK 200 R MERGE FOR SHELL (I) : 1.09400 REMARK 200 R SYM FOR SHELL (I) : 0.98200 REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3LJG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN:(HMMP12 F171D AT 927 MICRO-M + REMARK 280 ACETOHYDROXAMIC ACID AT 11.6 MILLI-M RESERVOIR: 45% PEG 4,000 REMARK 280 0.2 M IMIDAZOLE PIPERIDINE CRYOPROTECTION: 10% DI-ETHYLENE REMARK 280 GLYCOL, 10% 1.2-PROPANEDIOL, 10% GLYCEROL, 10% PEG 10,000, 10% REMARK 280 (AAB BUFFER 10% ACID/90% BASIC) 0.2 M NACL. FLASH COOLING IN REMARK 280 LN2. , PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 34.96000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.44500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.96000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.44500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 574 LIES ON A SPECIAL POSITION. REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 VAL A 235 N CA C O CB CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 206 -155.25 -143.05 REMARK 500 PRO A 238 49.84 -82.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 304 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 124 OD2 REMARK 620 2 ASP A 124 OD1 51.1 REMARK 620 3 GLU A 199 O 140.6 161.2 REMARK 620 4 GLU A 199 OE2 85.7 88.2 79.6 REMARK 620 5 GLU A 201 O 78.4 122.5 76.1 116.6 REMARK 620 6 HOH A 421 O 136.7 85.9 79.4 88.0 140.8 REMARK 620 7 HOH A 468 O 97.1 80.2 107.9 162.4 81.0 78.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 158 O REMARK 620 2 GLY A 190 O 167.0 REMARK 620 3 GLY A 192 O 94.5 92.6 REMARK 620 4 ASP A 194 OD1 89.5 101.3 89.6 REMARK 620 5 HOH A 408 O 87.4 84.3 173.3 96.9 REMARK 620 6 HOH A 412 O 83.5 86.8 82.1 168.7 91.7 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 168 NE2 REMARK 620 2 ASP A 170 OD2 106.4 REMARK 620 3 HIS A 183 NE2 115.1 119.7 REMARK 620 4 HIS A 196 ND1 104.0 96.1 113.1 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 305 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 175 OD1 REMARK 620 2 GLY A 176 O 90.4 REMARK 620 3 GLY A 178 O 86.8 85.5 REMARK 620 4 ILE A 180 O 92.2 177.2 93.7 REMARK 620 5 ASP A 198 OD2 96.3 86.6 171.5 94.1 REMARK 620 6 GLU A 201 OE2 166.6 87.9 79.9 89.3 96.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 218 NE2 REMARK 620 2 HIS A 222 NE2 99.3 REMARK 620 3 HIS A 228 NE2 106.8 95.1 REMARK 620 4 10B A 306 O2 132.3 125.6 86.4 REMARK 620 5 10B A 306 O7 95.1 92.3 155.3 70.3 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 10B A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 310 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 311 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 312 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 313 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4H3X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED REMARK 900 INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN REMARK 900 RELATED ID: 1RMZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED REMARK 900 WITH THE INHIBITOR NNGH AT 1.3 A RESOLUTION REMARK 900 RELATED ID: 4H30 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH REMARK 900 A TWIN INHIBITOR. REMARK 900 RELATED ID: 4GR0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX REMARK 900 WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470B REMARK 900 RELATED ID: 4GQL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX REMARK 900 WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470.1 REMARK 900 RELATED ID: 3LIK RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LJG RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LIL RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 4EFS RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR REMARK 900 RELATED ID: 3TSK RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR REMARK 900 RELATED ID: 3TS4 RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR DBREF 4H76 A 106 263 UNP P39900 MMP12_HUMAN 106 263 SEQADV 4H76 MET A 105 UNP P39900 EXPRESSION TAG SEQADV 4H76 ASP A 171 UNP P39900 PHE 171 ENGINEERED MUTATION SEQRES 1 A 159 MET GLY PRO VAL TRP ARG LYS HIS TYR ILE THR TYR ARG SEQRES 2 A 159 ILE ASN ASN TYR THR PRO ASP MET ASN ARG GLU ASP VAL SEQRES 3 A 159 ASP TYR ALA ILE ARG LYS ALA PHE GLN VAL TRP SER ASN SEQRES 4 A 159 VAL THR PRO LEU LYS PHE SER LYS ILE ASN THR GLY MET SEQRES 5 A 159 ALA ASP ILE LEU VAL VAL PHE ALA ARG GLY ALA HIS GLY SEQRES 6 A 159 ASP ASP HIS ALA PHE ASP GLY LYS GLY GLY ILE LEU ALA SEQRES 7 A 159 HIS ALA PHE GLY PRO GLY SER GLY ILE GLY GLY ASP ALA SEQRES 8 A 159 HIS PHE ASP GLU ASP GLU PHE TRP THR THR HIS SER GLY SEQRES 9 A 159 GLY THR ASN LEU PHE LEU THR ALA VAL HIS GLU ILE GLY SEQRES 10 A 159 HIS SER LEU GLY LEU GLY HIS SER SER ASP PRO LYS ALA SEQRES 11 A 159 VAL MET PHE PRO THR TYR LYS TYR VAL ASP ILE ASN THR SEQRES 12 A 159 PHE ARG LEU SER ALA ASP ASP ILE ARG GLY ILE GLN SER SEQRES 13 A 159 LEU TYR GLY HET ZN A 301 1 HET ZN A 302 1 HET CA A 303 1 HET CA A 304 1 HET CA A 305 1 HET 10B A 306 25 HET PGO A 307 5 HET PGO A 308 5 HET PGO A 309 5 HET PEG A 310 7 HET PEG A 311 7 HET PEG A 312 7 HET GOL A 313 6 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM 10B N-2-(BIPHENYL-4-YLSULFONYL)-N-2-(ISOPROPYLOXY)- HETNAM 2 10B ACETOHYDROXAMIC ACID HETNAM PGO S-1,2-PROPANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM GOL GLYCEROL HETSYN 10B N~2~-(BIPHENYL-4-YLSULFONYL)-N-HYDROXY-N~2~-(PROPAN-2- HETSYN 2 10B YLOXY)GLYCINAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CA 3(CA 2+) FORMUL 7 10B C17 H20 N2 O5 S FORMUL 8 PGO 3(C3 H8 O2) FORMUL 11 PEG 3(C4 H10 O3) FORMUL 14 GOL C3 H8 O3 FORMUL 15 HOH *201(H2 O) HELIX 1 1 ASN A 126 ASN A 143 1 18 HELIX 2 2 LEU A 212 GLY A 225 1 14 HELIX 3 3 SER A 251 TYR A 262 1 12 SHEET 1 A 5 LYS A 148 LYS A 151 0 SHEET 2 A 5 TYR A 113 ILE A 118 1 N ILE A 114 O LYS A 148 SHEET 3 A 5 ILE A 159 ALA A 164 1 O VAL A 161 N ARG A 117 SHEET 4 A 5 ALA A 195 ASP A 198 1 O PHE A 197 N VAL A 162 SHEET 5 A 5 ALA A 182 ALA A 184 -1 N HIS A 183 O HIS A 196 SHEET 1 B 2 TRP A 203 THR A 204 0 SHEET 2 B 2 THR A 210 ASN A 211 1 O THR A 210 N THR A 204 LINK OD2 ASP A 124 CA CA A 304 1555 1555 2.39 LINK OD1 ASP A 124 CA CA A 304 1555 1555 2.68 LINK O ASP A 158 CA CA A 303 1555 1555 2.38 LINK NE2 HIS A 168 ZN ZN A 302 1555 1555 2.01 LINK OD2 ASP A 170 ZN ZN A 302 1555 1555 1.97 LINK OD1 ASP A 175 CA CA A 305 1555 1555 2.39 LINK O GLY A 176 CA CA A 305 1555 1555 2.27 LINK O GLY A 178 CA CA A 305 1555 1555 2.34 LINK O ILE A 180 CA CA A 305 1555 1555 2.32 LINK NE2 HIS A 183 ZN ZN A 302 1555 1555 2.04 LINK O GLY A 190 CA CA A 303 1555 1555 2.33 LINK O GLY A 192 CA CA A 303 1555 1555 2.33 LINK OD1 ASP A 194 CA CA A 303 1555 1555 2.42 LINK ND1 HIS A 196 ZN ZN A 302 1555 1555 2.07 LINK OD2 ASP A 198 CA CA A 305 1555 1555 2.32 LINK O GLU A 199 CA CA A 304 1555 1555 2.30 LINK OE2 GLU A 199 CA CA A 304 1555 1555 2.42 LINK O GLU A 201 CA CA A 304 1555 1555 2.42 LINK OE2 GLU A 201 CA CA A 305 1555 1555 2.41 LINK NE2 HIS A 218 ZN ZN A 301 1555 1555 2.03 LINK NE2 HIS A 222 ZN ZN A 301 1555 1555 2.04 LINK NE2 HIS A 228 ZN ZN A 301 1555 1555 2.03 LINK ZN ZN A 301 O2 10B A 306 1555 1555 2.14 LINK ZN ZN A 301 O7 10B A 306 1555 1555 2.28 LINK CA CA A 303 O HOH A 408 1555 1555 2.30 LINK CA CA A 303 O HOH A 412 1555 1555 2.40 LINK CA CA A 304 O HOH A 421 1555 1555 2.42 LINK CA CA A 304 O HOH A 468 1555 1555 2.36 SITE 1 AC1 4 HIS A 218 HIS A 222 HIS A 228 10B A 306 SITE 1 AC2 4 HIS A 168 ASP A 170 HIS A 183 HIS A 196 SITE 1 AC3 6 ASP A 158 GLY A 190 GLY A 192 ASP A 194 SITE 2 AC3 6 HOH A 408 HOH A 412 SITE 1 AC4 5 ASP A 124 GLU A 199 GLU A 201 HOH A 421 SITE 2 AC4 5 HOH A 468 SITE 1 AC5 6 ASP A 175 GLY A 176 GLY A 178 ILE A 180 SITE 2 AC5 6 ASP A 198 GLU A 201 SITE 1 AC6 17 ILE A 180 LEU A 181 ALA A 182 LEU A 214 SITE 2 AC6 17 THR A 215 HIS A 218 GLU A 219 HIS A 222 SITE 3 AC6 17 HIS A 228 PRO A 232 VAL A 235 PHE A 237 SITE 4 AC6 17 THR A 239 TYR A 240 ZN A 301 HOH A 458 SITE 5 AC6 17 HOH A 492 SITE 1 AC7 8 PHE A 163 ALA A 164 GLU A 199 ARG A 256 SITE 2 AC7 8 GLN A 259 SER A 260 HOH A 433 HOH A 573 SITE 1 AC8 2 HIS A 172 ALA A 184 SITE 1 AC9 5 PHE A 185 GLY A 186 PEG A 312 HOH A 418 SITE 2 AC9 5 HOH A 501 SITE 1 BC1 7 HIS A 222 GLY A 225 LEU A 226 GLY A 227 SITE 2 BC1 7 HIS A 228 HOH A 427 HOH A 581 SITE 1 BC2 9 TYR A 113 VAL A 144 PRO A 146 ARG A 165 SITE 2 BC2 9 GLY A 166 ALA A 167 GLN A 259 HOH A 475 SITE 3 BC2 9 HOH A 572 SITE 1 BC3 8 ARG A 110 ASP A 129 PRO A 187 GLY A 188 SITE 2 BC3 8 THR A 205 PGO A 309 GOL A 313 HOH A 479 SITE 1 BC4 8 VAL A 108 TRP A 109 ARG A 110 LYS A 111 SITE 2 BC4 8 ASN A 126 GLY A 188 PEG A 312 HOH A 490 CRYST1 69.920 62.890 37.700 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014302 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015901 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026525 0.00000